- PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue PacBio
- PACB Forecasts Strong FY25 Revenue as Sales Gain Traction GuruFocus
- Here’s Why You Should Add PacBio Stock to Your Portfolio Nasdaq
- PacBio Announces Strong Preliminary Q4 and 2025 Revenue TipRanks
- PacBio Reports Preliminary Unaudited Q4 and Full Year 2025 Revenue Growth Quiver Quantitative